Congratulations on this important trial to Moritz Seiffert and everyone involved! DZHK Germany University Center of Cardiovascular Science (UCCS) UKE Hamburg

I have seen many HF talks listing IAS as an interventional therapy for HF symptoms while AF ablation in HF is often downright dismissed as free of robust evidence in the same talks. Why the disconnect in the community? Bogdan Enache David J. Cohen, MD, MSc Jason Andrade AGEP John Mandrola, MD

Hamburg rocks! Congratulations

Check out this super innovative work on clinical and genetic determinants of pericardial adiposity by Joel Rämö . This was not an easy task at all and it’s amazing to see how easy Joel made it seem!

Great overview of economic analyses in cardiac electrophysiology. Love the explanations and insightful for everyone interested in this topic. Also thanks for highlighting our CEA of early rhythm control in EAST-AFNET4
academic.oup.com/europace/artic…

our article academic.oup.com/europace/artic…

Great thread on the history of Brugada Syndrome.

FYI - medical factoid - this was also the inspiration for “The Nightmare on Elm Street”

Hearts in Rhythm Organization

Why is Brugada syndrome, which causes sudden cardiac death, so prevalent in Thailand and Southeast Asia? Our new preprint on medRxiv seeks to address this. A brief thread to describe the background and main findings of this study:
medrxiv.org/content/10.110…

Excited to share CarDS Lab's 1st App Store iOS entry - CarDS-Plus 📲

What is special about this App? Why did a research lab need one?

I have shared before how CarDS Lab has developed AI models to detect various cardiomyopathies on smartwatch⌚️ & portable ECGs ⚡️ (link in…

Important call to action by Cheng et al. @ESC_journals : Best way to stay in rhythm is to keep to the beat of optimal #CV health ➡️ bit.ly/3tRZ20P

Thanks #EJPC for letting Shino Kany and I share our thoughts ➡️ bit.ly/3NZOp2C

#EPeeps #CV prev Mass General Heart

1. Medicine is rapidly becoming an expensive hobby- working class people can no longer afford to become doctors given the poor salaries and huge debts on graduation.

I am the son of immigrants - I couldn't speak English until i was 5-i was born/ brought up in longsight,…

Jetzt open access lesen in der Zeitschrift
#HerzschrittmachertherapieundElektrophysiologie
👉go.sn.pub/JrpFLk
Roland Tilz Philipp Sommer David Duncker Victoria Johnson AGEP Young DGK Christian Veltmann Deutsche Gesellschaft für Kardiologie Daniel Steven

VHF ist eine Erkrankung des Alters. Aber oft sehen wir klinisch immer wieder junge Menschen mit VHF. R.Schnabel und ich haben zsm gefasst was Stand der Dinge bei der Genetik von VHF ist & wann man an eine Testung denken sollte.

AGEP Young DGK BDI
link.springer.com/article/10.100…

Congratulations Shino!

A terrific accomplishment and one more milestone in a career that is off to a fantastic start.

This Wednesday, my colleagues and I finally finished our European Society of Cardiology MSc at LSE Health Policy. Cannot stress how much I learned there and what a wonderful time I had in London. Thankful for our teachers, our great student group and support from Patrick Ellinor and UKE Hamburg.

Learn from an EP legend

Multiple RCTs w/consistent benefits across multiple outcomes is key. Not many treatments meet that bar. Validation across RCTs is the strongest form of evidence we have. Very hard to argue that AF ablation is not class I in HFrEF. Happy to debate anytime/place #cardiotwitter

Yes. First you have to look closely at the wording. The class 1A recommendation is “to improve symptoms, QOL, ventricular function, and cardiovascular outcomes”.
It does not say, “do this in everyone”
🧵

Great to see a strong showing of Patrick Ellinor lab members works (@LuChenWeng, Sean Jurgens and others) in the AF genetics section :) and for the first time recommendations for genetic testing.

Out now, our latest work on mapping the cardiovascular system at single cell resolution: biorxiv.org/content/10.110…

Led by the incredibly talented trio of Alessandro Arduini, Stephen Fleming & Ling Xiao from our teams Broad Institute, Bayer | Pharmaceuticals, MGH Cardiovascular Research Center & Mass General Heart.